News
Cmed to showcase own eSource technology at SCOPE 2018
Cmed, an innovative technology-led CRO, will demonstrate the eSource and live data analytics capabilities of encapsia®, a next generation clinical data suite, at Summit...
News
TraceLink Expands Leadership Team with New Senior Vice President of Engineering and New Chief Technology Officer Appointment
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient...
Press Releases
Lonza to Present Latest Research into More Physiologically Relevant ADME-Tox Models at the Society of Toxicology Meeting
During the Society of Toxicology Meeting from 11-15 March 2018 at the Henry B. González Convention Center in San Antonio, TX (USA), Lonza will...
News
CluePoints Wins Best Risk-Based Monitoring Solution in 2018 Biotechnology Awards
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has been honoured in this year’s Biotechnology Awards...
Clinical Trials
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC
ZZ Biotech announced that preliminary results of RHAPSODY, the company’s Phase 2 clinical trial in acute ischemic stroke patients, were presented at the 2018...
Press Releases
FDA approves Treatment: Lutathera® Gastroenteropancreatic Neuroendocrine Tumors
Novartis AG announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US FDA approval of its NDA for Lutathera® (lutetium...
Drug Research
Adverum Biotechnologies and Editas Medicine Extend Research Collaboration
Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced an extension of its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read